Date
- Friday, 16 November 2018
Location
- European Medicines Agency, Amsterdam, the Netherlands
This workshop offers the opportunity to share experience and plans to address challenges and opportunities for advancing regulatory science in the medicines research space, carrying out successful development programs and clinical studies.
It aims to reflect on initiatives in place at European and at national level, identify gaps and create synergies to collectively support new medicines and innovative healthcare solutions.
The workshop brings together academic groups already engaged in regulatory science or clinical research, the European Commission's DG Research and Innovation, European research infrastructures and regulators.
The European Medicines Agency (EMA) is co-hosting this workshop with the
Documents
Agenda - EU-Innovation network workshop with academia
List of participants - EU-Innovation network workshop with academia
Presentation - Session 1 - New clinical trial regulation
Presentation - Session 1 - The role of EMA in promoting innovation
Presentation - Session 1 - What is the EU Innovation Network
Presentation - Session 2 - DG RTD perspective
Presentation - Session 2 - EU funded initiatives - EU infrastructures - EATRIS
Presentation - Session 2 - EU funded initiatives - EU infrastructures - ECRIN
Presentation - Session 2 - EU funded initiatives - EU infrastructures - ELIXIR
Presentation - Session 2 - EU funded initiatives - CSA STARS
Presentation - Session 2 - EU funded initiatives - EU infrastructures - BBMRI
Presentation - Session 3 - AT - Answers to breakout sessions
Presentation - Session 3 - CZ - Answers to breakout sessions
Presentation - Session 3 - ES - Answers to breakout sessions
Presentation - Session 3 - IE - Answers to breakout sessions
Presentation - Session 3 - MT - Answers to breakout sessions